Merchavia Holdings and Investments Ltd Share Price TEL AVIV STOCK EXCHANGE
Equities
MRHL
IL0002570146
Biotechnology & Medical Research
Sales 2022 | 4.16M 1.13M 88.8M | Sales 2023 | 1.85M 500K 39.44M | Capitalization | 15.87M 4.3M 339M |
---|---|---|---|---|---|
Net income 2022 | -3M -812K -64.02M | Net income 2023 | -16M -4.33M -341M | EV / Sales 2022 | 5.47 x |
Net cash position 2022 | 4.25M 1.15M 90.66M | Net cash position 2023 | 2.2M 594K 46.87M | EV / Sales 2023 | 7.4 x |
P/E ratio 2022 |
-7.9
x | P/E ratio 2023 |
-0.98
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 28.52% |
Managers | Title | Age | Since |
---|---|---|---|
Eli Arad
CEO | Chief Executive Officer | 51 | 08/12/10 |
Ilan Goldstein
PSD | President | 63 | 25/10/14 |
Eran Schenker
CTO | Chief Tech/Sci/R&D Officer | 61 | 03/01/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ophir Shahaf
BRD | Director/Board Member | 57 | 13/03/19 |
Erez Alroy
BRD | Director/Board Member | 63 | 10/08/14 |
Rani Lifshitz
CHM | Chairman | 57 | 10/05/14 |
1st Jan change | Capi. | |
---|---|---|
+33.52% | 49.46B | |
+1.70% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.81% | 26.61B | |
-22.16% | 18.64B | |
+7.83% | 13.16B | |
+29.52% | 12.55B | |
+24.11% | 12.1B |